NNNN — Anbio Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- $939.61m
- $929.92m
- $6.71m
Annual cashflow statement for Anbio Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 2.54 | 10 | 2.25 |
| Depreciation | |||
| Non-Cash Items | — | -0.039 | -0.163 |
| Unusual Items | |||
| Changes in Working Capital | 1.65 | -5.53 | -1.2 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 4.18 | 4.45 | 0.898 |
| Other Investing Cash Flow Items | 0 | -1.53 | 1.73 |
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Cash from Investing Activities | 0 | -1.53 | 1.73 |
| Financing Cash Flow Items | — | 0 | -0.043 |
| Other Financing Cash Flow | |||
| Cash from Financing Activities | — | 0 | -0.043 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 4.18 | 2.92 | 2.59 |